Todd Franklin Watanabe - Net Worth and Insider Trading

Todd Franklin Watanabe Net Worth

The estimated net worth of Todd Franklin Watanabe is at least $14 Million dollars as of 2025-01-12. Todd Franklin Watanabe is the See Remarks of Arcutis Biotherapeutics Inc and owns about 1,005,744 shares of Arcutis Biotherapeutics Inc (ARQT) stock worth over $14 Million. Details can be seen in Todd Franklin Watanabe's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Todd Franklin Watanabe has not made any transactions after 2024-12-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Todd Franklin Watanabe

To

Todd Franklin Watanabe Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Todd Franklin Watanabe owns 1 companies in total, including Arcutis Biotherapeutics Inc (ARQT) .

Click here to see the complete history of Todd Franklin Watanabe’s form 4 insider trades.

Insider Ownership Summary of Todd Franklin Watanabe

Ticker Comapny Transaction Date Type of Owner
ARQT Arcutis Biotherapeutics Inc 2024-12-20 director & President and CEO

Todd Franklin Watanabe Latest Holdings Summary

Todd Franklin Watanabe currently owns a total of 1 stock. Todd Franklin Watanabe owns 1,005,744 shares of Arcutis Biotherapeutics Inc (ARQT) as of December 20, 2024, with a value of $14 Million.

Latest Holdings of Todd Franklin Watanabe

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ARQT Arcutis Biotherapeutics Inc 2024-12-20 1,005,744 13.81 13,889,325

Holding Weightings of Todd Franklin Watanabe


Todd Franklin Watanabe Form 4 Trading Tracker

According to the SEC Form 4 filings, Todd Franklin Watanabe has made a total of 42 transactions in Arcutis Biotherapeutics Inc (ARQT) over the past 5 years, including 2 buys and 40 sells. The most-recent trade in Arcutis Biotherapeutics Inc is the sale of 15,000 shares on December 20, 2024, which brought Todd Franklin Watanabe around $227,550.

Insider Trading History of Todd Franklin Watanabe

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Todd Franklin Watanabe Trading Performance

GuruFocus tracks the stock performance after each of Todd Franklin Watanabe's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Todd Franklin Watanabe is 13.72%. GuruFocus also compares Todd Franklin Watanabe's trading performance to market benchmark return within the same time period. The performance of stocks bought by Todd Franklin Watanabe within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Todd Franklin Watanabe's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Todd Franklin Watanabe

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 17.9 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 15.71 LIMIT LIMIT LIMIT LIMIT LIMIT

Todd Franklin Watanabe Ownership Network

Ownership Network List of Todd Franklin Watanabe

No Data

Ownership Network Relation of Todd Franklin Watanabe

Insider Network Chart

Todd Franklin Watanabe Owned Company Details

What does Arcutis Biotherapeutics Inc do?

Who are the key executives at Arcutis Biotherapeutics Inc?

Todd Franklin Watanabe is the director & President and CEO of Arcutis Biotherapeutics Inc. Other key executives at Arcutis Biotherapeutics Inc include See Remarks Patrick Burnett , Chief Commercial Officer Larry Todd Edwards , and SVP and General Counsel Masaru Matsuda .

Arcutis Biotherapeutics Inc (ARQT) Insider Trades Summary

Over the past 18 months, Todd Franklin Watanabe made 7 insider transaction in Arcutis Biotherapeutics Inc (ARQT) with a net sale of 68,471. Other recent insider transactions involving Arcutis Biotherapeutics Inc (ARQT) include a net sale of 206,209 shares made by Patrick Burnett , a net sale of 18,754 shares made by Masaru Matsuda , and a net sale of 70,000 shares made by Howard G. Welgus .

In summary, during the past 3 months, insiders sold 166,729 shares of Arcutis Biotherapeutics Inc (ARQT) in total and bought 12,788 shares, with a net sale of 153,941 shares. During the past 18 months, 414,956 shares of Arcutis Biotherapeutics Inc (ARQT) were sold and 113,840 shares were bought by its insiders, resulting in a net sale of 301,116 shares.

Arcutis Biotherapeutics Inc (ARQT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arcutis Biotherapeutics Inc Insider Transactions

No Available Data

Todd Franklin Watanabe Mailing Address

Above is the net worth, insider trading, and ownership report for Todd Franklin Watanabe. You might contact Todd Franklin Watanabe via mailing address: C/o Arcutis Biotherapeutics, Inc., 2945 Townsgate Road, Suite 110, Westlake Village Ca 91361.